BALESTRINO, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 17.139
AS - Asia 88
SA - Sud America 36
AF - Africa 1
NA - Nord America 1
Totale 17.265
Nazione #
IT - Italia 17.137
CN - Cina 73
BR - Brasile 27
SG - Singapore 7
VN - Vietnam 7
AR - Argentina 4
EC - Ecuador 2
CL - Cile 1
ID - Indonesia 1
PE - Perù 1
PY - Paraguay 1
RU - Federazione Russa 1
SE - Svezia 1
TN - Tunisia 1
US - Stati Uniti d'America 1
Totale 17.265
Città #
Genova 11.104
Genoa 3.617
Rapallo 1.305
Vado Ligure 1.069
Beijing 41
Bordighera 40
Ho Chi Minh City 3
Brasília 2
Hanoi 2
Singapore 2
São Paulo 2
Anápolis 1
Araras 1
Ashburn 1
Asunción 1
Betim 1
Brescia 1
Cachoeiras de Macacu 1
Campo Largo 1
Canoas 1
Chelyabinsk 1
Da Nang 1
Empalme San Vicente 1
Estación Colina 1
Ferraz de Vasconcelos 1
Floriano 1
Fortaleza 1
Guayaquil 1
Hangzhou 1
Hải Dương 1
Itapevi 1
Ituzaingó 1
Joinville 1
Juiz de Fora 1
Jönköping 1
Ksar Hellal 1
La Plata 1
Laguna 1
Lima 1
Matias Barbosa 1
Medan 1
Mogi Guaçu 1
Niterói 1
Nova Palmeira 1
Ourinhos 1
Portoviejo 1
Rada Tilly 1
Santa Luzia 1
São Lourenço 1
São Mateus 1
Viamão 1
Vitória da Conquista 1
Totale 17.228
Nome #
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity 227
A new method to synthesize creatine derivatives. 217
Angioedema after rt-PA treatment in acute ischemic stroke may be attended by shock and worsening of stroke outcome 217
Activation of cerebellar granule cells GABAA receptors by guanidinoacetate 197
A Novel Method to Synthesize Phosphocreatine and Phosphocreatine Prodrugs 195
Creatine salts provide neuroprotection even after partial impairment of the creatine transporter 193
Detection of electrophysiological indicators of neurotoxicity in human and rat brain slices by a three-dimensional microelectrode array. 191
Protective effects of some creatine derivatives in brain tissue anoxia. 187
Altered Handwriting Suggests Cognitive Impairment and May Be Relevant to Posthumous Evaluation 187
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 176
Effects of exogenous creatine on population spike amplitude and on postanoxic hyperexcitability in brain slices. 170
Creatine ethyl ester: A new substrate for creatine kinase 170
Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency 169
Effects on Energy Metabolism of Two Guanidine Molecules, (Boc)2-Creatine and Metformin 169
Pathophysiology of pH and Ca2+ in bloodstream and brain. 168
Effects of Amide Creatine Derivatives in Brain Hippocampal Slices, and Their Possible Usefulness for Curing Creatine Transporter Deficiency. 161
Changes in extracellular action potential detect kainic acid and trimethyltin toxicity in hippocampal slice preparations earlier than do MAP2 density measurements 159
Could Mannitol-Induced Delay of Anoxic Depolarization be Relevant in Stroke Patients? 159
Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices. 158
Support of Nerve Conduction by Respiring Myelin Sheath: Role of Connexons. 158
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. 158
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. 157
In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate. 157
Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro. 157
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. 156
Biacil creatina carbossil derivata, suoi usi e suo procedimento di sintesi 156
Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 153
Intracerebroventricular administration of creatine protects against damage by global cerebral ischemia in rat 153
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 153
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. 152
Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. 151
Creatine as a Candidate to Prevent Statin Myopathy 149
Delirium in the acute phase after stroke: comparison between methods of detection 148
Handwriting as a gauge of cognitive status: a novel forensic tool for posthumous evaluation of testamentary capacity 146
Seasonal differences and protection by creatine or arginine pretreatment in ischemia of mammalian and molluscan neurons in vitro. 145
Validation of a simple method for atrial fibrillation screening in patients with stroke 144
Bannwarth syndrome: report of two cases 143
A method of synthesizing creatine derivatives 143
The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds 143
Neuroprotection by creatine-derived compounds. 142
Churg-Strauss syndrome mimicking myocardial infarction with cerebral vascular involvement. 142
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development 142
The antiepileptic effect of low-dose amino-phosphono-valeric acid (APV) is not enhanced by phosphatidylserine association. 140
A novel hypothesis about mechanisms affecting conduction velocity of central myelinated fibers. 139
National Institutes of Health Stroke Scale in patients with primary intracerebral hemorrhage 139
The excitatory amino acid antagonist amino-phosphono-valeric acid (APV) provides protection against penicillin-induced epileptic activity in the rat. 139
Biacil carboxy derived creatine, its uses and its synthesis process 137
The role of spreading depression-like hypoxic depolarization in irreversible neuron damage, and its prevention 136
Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. 134
Systemic administration of mesenchymal stem cells increases neuron survival after global cerebral ischemia in vivo (2VO). 134
Effects of CO2 and interstitial pH changes on synaptic transmission in CA1 region of rat hippocampus in vitro. 133
Applicazione terapeutica di un derivato di creatina 133
Controlling the flow of energy: inhibition and stimulation of the creatine transporter. 132
NMDA antagonists: lack of protective effect against hypoxic damage in CA1 region of hippocampal slices 131
Structural organization of astrocytes in the rat hippocampus in the post-ischemic period. 131
In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism 131
Spreading depression-like hypoxic depolarization in CA1 and fascia dentata of hippocampal slices: relationship to selective vulnerability 128
Advances in the Preclinical Study of Ischemic Stroke 128
Studies on anoxic depolarization. 127
Measurements of (Na+, K+)ATPase after in vitro hypoxia and reoxygenation are affected by methods of membrane preparation 127
Complessi di fosfocreatina. 126
Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage 126
Abnormalities of Na/K ATPase in migraine with aura 124
An array of Pt-tip microelectrodes for extracellular monitoring of activity of brain slices 123
Uses and abuses of in vitro systems in the study of the pathophysiology of the central nervous system. 121
The effects of moderate changes of extracellular K+ and Ca2+ on synaptic and neural function in the CA1 region of the hippocampal slice. 120
Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle 120
Involvement of S-100 protein in anoxic long-term potentiation. 119
Endovascular treatment for acute ischemic stroke. 119
Trigeminal neuralgia in pontine ischaemia 119
Spreading depression-like depolarization and selective vulnerability of neurons. A brief review. 118
Advances in the treatment of ischemic stroke. 118
Concentration of carbon dioxide, interstitial pH and synaptic transmission in hippocampal formation of the rat 118
Screening for Fabry disease in patients with ischaemic stroke at young age: the Italian Project on Stroke in Young Adults 118
Chlorpromazine protects brain tissue in hypoxia by delaying spreading depression-mediated calcium influx. 117
Thrombolysis for Ischemic Stroke in Patients Aged 90 Years or Older. 117
Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration 117
In vitro neurotoxicology tests based on the coupling of brain slices to silicon microelectrode arrays. 116
Antiserum against S-100 protein prevents long-term potentiation through a cAMP-related mechanism 115
Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives. 115
Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine 115
Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease 115
Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke 114
Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. 110
Safe and effective outcome of intravenous thrombolysis for acute ischemic stroke in patients aged 90 years or older 110
Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome 110
Malattie cerebrovascolari 108
Trearments affecting conduction velocity of central myelinated fibers: results and novel hypothesis. 108
Effects of intravenous infusion of bone marrow stromal cells after global cerebral ischemia 108
Block of (Na+,K+)ATPase with ouabain induces spreading depression-like depolarization in hippocampal slices 106
Development of vulnerability to hypoxic damage in in vitro hippocampal neurons 106
Increase of cerebral phosphocreatine in normal rats after intracerebroventricular administration of creatine 106
Procedimento per sintetizzare derivati della creatina 105
Therapeutic application of a derivative of creatine 105
Statin-induced myopathy prevented by creatine administration 105
Prevalence of patent foramen ovale in ischaemic stroke in italy: Results of SISIFO study 104
Cognitive stimulation therapy in Italian patients: a pilot study 103
Neuropatia ereditaria da compressione: studio clinico e neurofisiologico di una famiglia 102
Vasoreactive response to hyperemia in CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infartcs and Leukoencephalopathy) patients 102
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 101
Totale 13.846
Categoria #
all - tutte 55.758
article - articoli 47.062
book - libri 720
conference - conferenze 1.851
curatela - curatele 0
other - altro 0
patent - brevetti 3.007
selected - selezionate 0
volume - volumi 3.118
Totale 111.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021841 0 0 0 0 79 147 148 100 90 116 92 69
2021/20221.760 65 121 134 209 35 123 119 415 86 149 97 207
2022/20231.593 186 109 19 180 238 275 8 90 284 21 158 25
2023/2024809 53 111 38 93 75 112 70 52 33 14 46 112
2024/20252.581 52 196 75 215 357 256 202 454 120 117 259 278
2025/20261.206 554 114 198 318 22 0 0 0 0 0 0 0
Totale 17.563